Fig. 5From: Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signalingKPNA2 as a prognosis marker in ovarian cancer. (a) Expression of KPNA2 in tumor (20 cases) and adjacent normal tissues (20 cases). (b) Kaplan-Meier curves based on KPNA2 expression were drawn for overall survival in 35 patients. (c) Overall survival (OS) curves calculated by PrognoScan tool. (d) OS curves calculated by Kaplan-Meier Plotter AnalysisBack to article page